Sharecare, the digital health company that helps people manage all their health in one place, today announced the launch of a free clinically validated COVID-19 chatbot screener – developed in partnership with IPsoft and NTT DATA – to provide the general public with a helpful way to anonymously self-screen for the novel coronavirus. Accessible via Sharecare’s website and smartphone app, the screener is available for free to any U.S. organization to put on their website in an effort to empower people to reduce the spread of COVID-19 while easing the strain on healthcare providers.

Sharecare’s integration of Amelia and AskMD

The COVID-19 chatbot screener is a dynamic COVID-19 consult algorithm based on clinical guidelines from the CDC, WHO and other major medical organizations as well as primary research studies from medical literature. This tool is consistently updated to reflect the latest, evidence-based information to provide accurate, actionable “next steps” guidance.

Source: hitconsultant.net